Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review.
LABAN, NM; GOODIER, MR; Bosomprah, S; Simuyandi, M; Chisenga, C; Chilyabanyama, ON; Chilengi, R;
2022
VIRUSES-BASEL, (2022).14 3 10.3390/v14030459.
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin, DR; Higdon, MM; Abu-Raddad, LJ; Andrews, N; Araos, R; Goldberg, Y; Groome, MJ; Huppert, A; O'Brien, KL; SMITH, PG; WILDER-SMITH, A; Zeger, S; Deloria Knoll, M; Patel, MK;
2022
Lancet, (2022).399 10328 10.1016/S0140-6736(22)00152-0.
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali.
GRANT, J; Sagara, I; Zongo, I; CAIRNS, M; Yerbanga, RS; Diarra, M; Zoungrana, C; Issiaka, D; Nikièma, F; Sompougdou, F; Tapily, A; Kaya, M; Haro, A; Sanogo, K; Sienou, AA; Traore, S; Thera, I; Yalcouye, H; Kuepfer, I; SNELL, P; MILLIGAN, P; Ockenhouse, C; Ofori-Anyinam, O; Tinto, H; Djimde, A; ... Ouédraogo, J-B.
2022
Malaria Journal, (2022).21 1 10.1186/s12936-022-04077-x.
Evolving measles status and immunization policy development in six European countries.
Vojtek, I; LARSON, H; Plotkin, S; Van Damme, P;
2022
Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2031776.
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Sparrow, E; ADETIFA, I; Chaiyakunapruk, N; Cherian, T; Fell, DB; Graham, BS; Innis, B; Kaslow, DC; Karron, RA; Nair, H; Neuzil, KM; Saha, S; SMITH, PG; Srikantiah, P; Were, F; Zar, HJ; Feikin, D;
2022
Vaccine, (2022).40 26 10.1016/j.vaccine.2022.02.040.
Vaccination coverage determinants in low uptake areas of China: a qualitative study of provider perspectives in Sichuan, Guangdong, and Henan Provinces.
Lin, S-Y; Zhang, S-Y; CHANTLER, T; Sun, FY; Zou, J-T; Cheng, J-J; Chen, Y-Q; Sun, M; HOWARD, N;
2022
Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2030623.
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Kasstan, B; MOUNIER-JACK, S; Letley, L; GASKELL, KM; ROBERTS, CH; Stone, NR H; LAL, S; EGGO, RM; MARKS, M; CHANTLER, T;
2022
Vaccine, (2022).40 14 10.1016/j.vaccine.2022.02.056.
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
PARKER, EP K; Desai, S; Marti, M; Nohynek, H; Kaslow, DC; Kochhar, S; O'Brien, KL; Hombach, J; WILDER-SMITH, A;
2022
The Lancet Global Health, (2022).10 3 10.1016/S2214-109X(21)00593-3.
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Kochhar, S; Barreira, D; Beattie, P; Cavaleri, M; Cravioto, A; Frick, MW; Ginsberg, AM; Hudson, I; Kaslow, DC; Kurtz, S; Lienhardt, C; Madhi, SA; Morgan, C; Momeni, Y; Patel, D; Rees, H; Rogalski-Salter, T; Schmidt, A; Semete-Makokotlela, B; Voss, G; WHITE, RG; Zignol, M; Giersing, B;
2022
Vaccine, (2022).40 12 10.1016/j.vaccine.2021.10.062.
Improving estimates of social contact patterns for the airborne transmission of respiratory pathogens.
MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;
2022
(2022). 10.1101/2022.02.06.22270386.